SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-18-000028
Filing Date
2018-08-14
Accepted
2018-08-14 08:16:40
Documents
14
Period of Report
2018-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201808148-k.htm 8-K 36169
2 EXHIBIT 99.1 earningspressreleaseq420.htm EX-99.1 44364
3 a201808148karrayquart_image1.jpg GRAPHIC 146580
4 earningspressreleaseq420001.jpg GRAPHIC 199703
5 earningspressreleaseq420002.jpg GRAPHIC 282843
6 earningspressreleaseq420003.jpg GRAPHIC 269416
7 earningspressreleaseq420004.jpg GRAPHIC 256742
8 earningspressreleaseq420005.jpg GRAPHIC 246742
9 earningspressreleaseq420006.jpg GRAPHIC 259135
10 earningspressreleaseq420007.jpg GRAPHIC 262135
11 earningspressreleaseq420008.jpg GRAPHIC 279624
12 earningspressreleaseq420009.jpg GRAPHIC 167391
13 earningspressreleaseq420010.jpg GRAPHIC 121899
14 earningspressreleaseq420011.jpg GRAPHIC 15573
  Complete submission text file 0001100412-18-000028.txt   3536877
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 181014397
SIC: 2834 Pharmaceutical Preparations